David C. Linch
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemia.
Journal: Blood
Published: August 19, 2025
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.
Journal: Blood
Published: August 19, 2025
Early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma: long-term results of a randomised, phase 3 trial.
Journal: The Lancet. Haematology
Published: November 12, 2024
In Situ Tracking of TCRβ Isoforms for Detection of T Cell Clonality: Implication for Precision Diagnosis and Targeted Immunotherapy of T-Cell Neoplasms.
Journal: Hematological oncology
Published: September 22, 2024
Quality of life in advanced-stage, asymptomatic, non-bulky follicular lymphoma treated with rituximab shows significant improvement compared with watchful-waiting.
Journal: British journal of haematology
Published: July 28, 2024
Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients.
Journal: Journal of hematology & oncology
Published: May 19, 2024
Prognostic impact of CEBPA mutational subgroups in adult AML.
Journal: Leukemia
Published: October 30, 2023
Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma.
Journal: Frontiers in oncology
Published: July 26, 2023
High inter-follicular spatial co-localization of CD8+FOXP3+ with CD4+CD8+ cells predicts favorable outcome in follicular lymphoma.
Journal: Hematological oncology
Published: January 29, 2022
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
Journal: Nature communications
Published: January 05, 2022
Last Updated: 09/26/2026